Mukka Proteins Ltd Financials
Company Logo

Mukka Proteins Ltd Financial Statement

Mukka Proteins Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue129.01
Operating Expense117.84
Net Profit2.17
Net Profit Margin1.68
Earning Per Share0.07
EBIDTA11.25
Effective Tax Rate-3.31

Mukka Proteins Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,268.54
Operating Expenses Annual1,187.16
Operating Profit Annual101.46
Interest Annual24.19
Depreciation5.62
Net Profit Annual62.76
Tax Annual8.89

Mukka Proteins Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning20.62
Cash Flow from Operations-144.44
Cash Flow from Investing-43.04
Cash Flow from Financing258.05
Cash Flow at the End91.18

Mukka Proteins Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)8
PBIT Margin (%)7.56
PBT Margin (%)7.25
Net PROFIT Margin (%)4.95
Return On Networth / Equity (%)25.78
Return On Networth /Employed (%)18.08
Return On Assets (%)11.82
Total Debt / Equity (X)1.17
Asset Turnover Ratio (%)2.39

Mukka Proteins Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual58.46
Total Current Assets Annual749.71
Non Current Assets Annual101.43
Total Shareholders Funds Annual365.17
Total Assets Annual851.14

Mukka Proteins Ltd Earning Calls

EPS (INR)

Expected

0.07

Reported

0.07

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 31.87%

Get Your FAQs Right

As of Dec 8, 2024, Mukka Proteins Ltd has a market capitalization of 1,094.10 Cr. Value Research classifies it as a Small-Cap company.
No, Mukka Proteins Ltd is not debt-free with a debt-to-equity ratio of 0.91.
In FY 2023 , Mukka Proteins Ltd recorded a total revenue of approximately 1,230.82 Cr marking a significant milestone in the company's financial performance.
Mukka Proteins Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.3% annually, respectively..
Mukka Proteins Ltd's current PE ratio is 17.43.
Mukka Proteins Ltd's ROCE averaged 14.9% from the FY ending March 2022 to 2024, with a median of 13.7%. It peaked at 19.5% in March 2023, reflecting strong capital efficiency over the period..
Mukka Proteins Ltd's latest EBIT is Rs. 95.84 Cr, surpassing the average EBIT of Rs. 64.77 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions